retatrutide peptide injection 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide Injection: Package Insert /

Investigating the same primary endpoint, TRANSCEND-T2D-2 (NCT06260722) will compare retatrutide to semaglutide in people with inadequately controlled T2D (treated with oral glucose-lowering treatments) over 26 months

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 agonist and a different molecule

These results mean that many users gave more than one reason for cutting back on their doses

For researchers exploring the best peptide stacks for weight loss , understanding this thermogenic component reframes how you think about metabolic intervention entirely

GLP-1 receptor agonists for weight reduction in people living with obesity